MTOR and hepatocellular carcinoma: Moreover, the activity of signaling pathways, for example, the aberrant Wnt/β-catenin pathway and the increased activity of the PI3K/Akt/mTOR signaling pathway, is associated with poor prognosis, early recurrence, and reduced survival in HCC [164,165].